about
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cellsThe Origin and Activities of IgA1-Containing Immune Complexes in IgA NephropathyDoes tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy?NF-κB in inflammation and renal diseasesMolecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospectsMesangial pathology in glomerular disease: targets for therapeutic intervention.Do the mutations of C1GALT1C1 gene play important roles in the genetic susceptibility to Chinese IgA nephropathy?A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityRole of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathyUrinary CXCL1: a novel predictor of IgA nephropathy progression.IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cellsGlycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology.Galectin-8 in IgA nephritis: decreased binding of IgA by galectin-8 affinity chromatography and associated increased binding in non-IgA serum glycoproteins.Immunoglobulin A nephropathy associated with Plasmodium falciparum malaria.Serum galactose-deficient IgA1 levels in children with IgA nephropathy.Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathyThe Gne M712T mouse as a model for human glomerulopathy.The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progressionIgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum GlycoproteinsIgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.Structural glycobiology: a game of snakes and ladders.Recent insights into the biological roles of mucin-type O-glycosylationCHO microRNA engineering is growing up: recent successes and future challenges.Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.TLR1 polymorphism rs4833095 as a risk factor for IgA nephropathy in a Chinese Han population: A case-control study.Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy.Pathological role of tonsillar B cells in IgA nephropathy.Glycosylation of IgA1 and pathogenesis of IgA nephropathy.Pathological scenario with the mannose-binding lectin in patients with IgA nephropathy.IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage.Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.Immunoglobulin A nephropathy: a pathophysiology view.Interaction of C1GALT1-IL5RA on the susceptibility to IgA nephropathy in Southern Han Chinese.
P2860
Q24680134-AF6C1A5A-442A-4BFE-854A-2ADD8F84A6D2Q26752555-45385A2A-B9B6-433E-B1B5-A99B4656771BQ26852296-48F93A60-43A4-4D42-A3F9-9AEB0A88C447Q27021276-9083DBE7-AE76-4D46-8CA5-6E4124FAE758Q27686945-528498A1-95CD-4B87-BC71-151EC7B63244Q30429535-52C50155-F955-4CA4-869F-275060DFDCCFQ33506540-4570C517-E472-4507-9A7F-75792ED636C9Q33654763-AAB8CFE8-4145-45C7-B6C6-43BE645ED29CQ34126171-C8B069E5-015B-4EE9-96C1-9269E7F19265Q34608317-15D23BD2-A679-4F39-BD33-2422C640F052Q34655605-1D7EE741-D29D-4895-928A-D4BD20496608Q35224820-F81C884E-2F99-4756-959E-829DFFFFCD24Q35468711-C20F5E6C-8882-4CBA-AB6A-95E42ED10058Q35725275-C2607163-60FA-45E1-B6A0-7FE783F35CF1Q35834840-A1B31725-404C-4B2D-848D-A7DD8BB66BDDQ35859262-2D33AD65-4703-4E71-A1CF-8E4D3C3A550EQ35870949-5C36B879-61C5-4372-AF24-0E3CF337C281Q35917473-343F4373-037E-4768-BEC4-7896A6F30517Q35952076-EB948A30-D363-4DDB-8F43-1ACAB16FA007Q36237466-266EAFDD-EBD4-453A-B362-73312A6E777DQ36303703-52E1E08D-50D3-45D9-B0C9-A28525F4D304Q36348802-E67503D2-064B-48CA-BF68-3469B2C1762AQ36456627-2A96C4AB-EC53-44C6-927F-F50F2FA10A30Q36577108-305A1596-FC42-4A6A-BBFD-755687AB528CQ36965109-68C4FC29-0100-4125-B6C1-4695E52848C1Q37129248-30CF5663-F31A-48D7-947A-9284306BD09FQ37130137-BEF30180-20FC-4BB0-AEA5-6EF414F13911Q37372564-CDC93383-2A1E-446B-A260-9188DA2918BDQ37471445-498655A3-A6BD-4D00-A2F9-8C4CAEA3D0A5Q37525267-821FF4AC-2E62-43D0-A98D-4CBAE93DEC70Q37696261-C00C9F83-A7C8-421D-91EA-4682BB17E180Q37733547-5399252D-35C1-42B5-8B59-C8679BA631F3Q37904711-A23CA0DE-AB13-424C-92C3-77670B27B4C1Q37995525-652F6125-B656-4CFD-93A3-09A1FED905ECQ38008323-D80499BF-B7A5-4CD3-B2CF-FF86FC070152Q38017623-D7B56006-A5D3-4085-BC27-6FC058A77A51Q38325438-37B514E4-D01C-40D6-B7A2-29B7B4AE6F9FQ38817381-4A938839-31D3-4F0A-96A5-D039D4509714Q38879517-16F0EE97-F408-43AD-9F59-476CB4BAB542Q39512293-97CD8DCE-1ED1-407E-938A-414D403DE09E
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Aberrant glycosylation in IgA nephropathy (IgAN).
@ast
Aberrant glycosylation in IgA nephropathy (IgAN).
@en
type
label
Aberrant glycosylation in IgA nephropathy (IgAN).
@ast
Aberrant glycosylation in IgA nephropathy (IgAN).
@en
prefLabel
Aberrant glycosylation in IgA nephropathy (IgAN).
@ast
Aberrant glycosylation in IgA nephropathy (IgAN).
@en
P1433
P1476
Aberrant glycosylation in IgA nephropathy (IgAN).
@en
P2093
Alessandro Amore
Rosanna Coppo
P304
P356
10.1111/J.1523-1755.2004.05407.X
P407
P577
2004-05-01T00:00:00Z
P5875
P6179
1026257688